Patents Assigned to Cell MDX, LLC
  • Patent number: 10626464
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: April 21, 2020
    Assignee: Cell MDX, LLC
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Patent number: 10494675
    Abstract: This invention provides a set of biological markers that are useful for detecting cancer. This invention further provides methods of using those biological markers for the diagnosis, prognosis, or monitoring of cancer.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: December 3, 2019
    Assignee: Cell MDX, LLC
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno